Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 8;25(14):3118.
doi: 10.3390/molecules25143118.

5-Aryl-2-(3,5-dialkyl-4-hydroxyphenyl)-4,4-dimethyl-4 H-imidazole 3-Oxides and Their Redox Species: How Antioxidant Activity of 1-Hydroxy-2,5-dihydro-1 H-imidazoles Correlates with the Stability of Hybrid Phenoxyl-Nitroxides

Affiliations

5-Aryl-2-(3,5-dialkyl-4-hydroxyphenyl)-4,4-dimethyl-4 H-imidazole 3-Oxides and Their Redox Species: How Antioxidant Activity of 1-Hydroxy-2,5-dihydro-1 H-imidazoles Correlates with the Stability of Hybrid Phenoxyl-Nitroxides

Svetlana A Amitina et al. Molecules. .

Abstract

Cyclic nitrones of the imidazole series, containing a sterically hindered phenol group, are promising objects for studying antioxidant activity; on the other hand, they can form persistent hybrid phenoxyl-nitroxyl radicals (HPNs) upon oxidation. Here, a series of 5-aryl-4,4-dimethyl-4H-imidazole 3-oxides was obtained by condensation of aromatic 2-hydroxylaminoketones with 4-formyl-2,6-dialkylphenols followed by oxidation of the initially formed N-hydroxy derivatives. It was shown that the antioxidant activity of both 1-hydroxy-2,5-dihydroimidazoles and 4H-imidazole 3-oxides increases with a decrease in steric volume of the alkyl substituent in the phenol group, while the stability of the corresponding HPNs generated from 4H-imidazole 3-oxides reveals the opposite tendency.

Keywords: 4H-imidazole 3-oxides; antioxidants; cyclic hydroxylamines; electron paramagnetic resonance; hybrid phenoxyl–nitroxides; sterically hindered phenols.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Chemical structures of nitrones with a lateral or exocyclic C=N+O group.
Scheme 2
Scheme 2
Examples of cyclic nitrones with an endocyclic C=N+O group.
Scheme 3
Scheme 3
Examples of spin traps, antioxidants, and neuroprotectors containing α,α′-dialkyl–substituted phenolic or nitrone groups.
Scheme 4
Scheme 4
Synthesis of initial 4-formylphenols 23.
Scheme 5
Scheme 5
Synthesis of key compounds: 2,4-diaryl-1-hydroxy-2,5-dihydroimidazoles 20, 2,5-diaryl-4H-imidazole 3-oxides 21, and HPNs 22. Reagents and conditions: (i) R3 = OH: (Z)-PhCH=NOH, EtONa (2 equiv), EtOHabs, 0 °C → 20 °C, 72 h, 65%; (ii) R3 = H, F, Br: NH2OH⋅HCl (5 equiv), MeONa (4 equiv), MeOH, rt→Δ (6–8 h), 60–85%; (iii) R3 = OH: NH2OH⋅HCl, EtOH, rt, 48 h, then 25% aq NH3, 80%; (iv) R3 = H, F, Br: HClconc, Δ, 25–50 min, 75–85%; (v) R3 = H, F, Br, OH: NH4OAc (6–10 equiv), 4-formylphenol 23, MeOH (or EtOHabs), rt, 6–12 h, then 0 °C, 12 h, 68–98%; (vi) R3 = H, F, Br, OH: Cu(OAc)2⋅H2O (20 mol%), 16% aq NH3, O2, MeOH, rt, 1–6 h, 81–100%; (vii) R3 = H, F, Br: CHCl3, PbO2, 296 K, 1 min, then dilution with PhMe, argon, 75–85% for 22e,j,o.
Scheme 6
Scheme 6
Possible oxidative transformations of 1-hydroxy-2,5-dihydroimidazoles under the action of peroxide radicals as exemplified by diisopropyl substituted derivative 20h. Colored circles indicate the sites where the predominant attack of the peroxide radical occurs.
Figure 1
Figure 1
Chemical structures of HPNs 22a–o.
Figure 2
Figure 2
EPR spectra recorded for diluted and oxygen-free toluene solutions of HPNs at 295 K: (a) 22a, (b) 22b, (c) 22c, and (d) 22d. Black curve: experimental spectra; red curve: simulated spectra with the parameters listed in Table 3.
Figure 3
Figure 3
EPR spectra acquired for diluted and oxygen-free toluene solutions of HPNs at 295 K: (a) 22e, (b) 22j, and (c) 22o.
Figure 4
Figure 4
Mulliken atomic spin populations for (a)22e, (b)22j, (c)22o calculated at the UB3LYP/6-31G(d) level of theory.
Figure 5
Figure 5
A time-dependent EPR spectrum recorded for a diluted and oxygen-free solution of HPN 22a in PhMe: (a,d) immediately after radical formation; (b,e) at 1 h after radical formation; (c,f) 2 h after radical formation. The figure shows spectra that are normalized to the maximum on the y-axis (a,b) as well as non-normalized spectra (df).
Figure 6
Figure 6
Kinetics of decomposition of HPNs 22c and 22d in diluted and oxygen-free toluene solutions.

References

    1. Grigor’ev I.A. Nitrones: Novel strategies in synthesis. In: Feuer H., editor. Nitrile Oxides, Nitrones and Nitronates in Organic Synthesis: Novel Strategies in Synthesis. 2nd ed. John Wiley@Sons Inc.; Hoboken, NJ, USA: 2007. pp. 129–434. - DOI
    1. Murahashi S.-I., Imada Y. Synthesis and transformations of nitrones for organic synthesis. Chem. Rev. 2019;119:4684–4716. doi: 10.1021/acs.chemrev.8b00476. - DOI - PubMed
    1. Towner R.A., Floyd R.A. Nitrones as potent anticancer therapeutics. In: Batinić-Haberle I., Rebouças J.S., Spasojević I., editors. Redox-Active Therapeutics, Oxidative Stress in Applied Basic Research and Clinical Practice. Springer International Publishing; Cham, Switzerland: 2016. pp. 245–264. - DOI
    1. Rosselin M., Poeggeler B., Durand G. Nitrone derivatives as therapeutics: From chemical modification to specific-targeting. Curr. Topics Med. Chem. 2017;17:2006–2022. doi: 10.2174/1568026617666170303115324. - DOI - PubMed
    1. Oliveira C., Benfeito S., Fernandes C., Cagide F., Silva T., Borges F. NO and HNO donors, nitrones, and nitroxides: Past, present, and future. Med. Res. Rev. 2018;38:1159–1187. doi: 10.1002/med.21461. - DOI - PubMed

MeSH terms